niceritrol has been researched along with Complications of Diabetes Mellitus in 1 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentaerythritol tetranicotinate (Perycit), at an oral dosage of 750 mg daily, was given to 12 patients with idiopathic hyperlipidemia and to 12 patients with hyperlipidemia superimposed with diabetes mellitus (DM)." | 2.66 | The antilipemic effectiveness of pentaerythritol tetranicotinate on hyperlipidemic patients with or without diabetes mellitus--a double-blind, randomized and two-period change-over experiment. ( Chen, JJ; Chen, RL; Chern, JC; Ho, LT; Hsu, SC; Jap, TS; Kwok, CF; Wu, MS, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, LT | 1 |
| Chern, JC | 1 |
| Hsu, SC | 1 |
| Chen, RL | 1 |
| Kwok, CF | 1 |
| Wu, MS | 1 |
| Chen, JJ | 1 |
| Jap, TS | 1 |
1 trial available for niceritrol and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
The antilipemic effectiveness of pentaerythritol tetranicotinate on hyperlipidemic patients with or without diabetes mellitus--a double-blind, randomized and two-period change-over experiment.
Topics: Clinical Trials as Topic; Diabetes Complications; Double-Blind Method; Humans; Hyperlipidemias; Nice | 1985 |